[Hormonal premedication in endometrium ablation--results of a prospective comparative study]. / Hormonale Vorbehandlung für die Endometriumablation--Ergebnisse einer prospektiven Vergleichsstudie.
Zentralbl Gynakol
; 118(5): 291-4, 1996.
Article
en De
| MEDLINE
| ID: mdl-8701626
ABSTRACT
In a prospective study in 40 patients the pretreatment for endometrial ablation with a gestagen (Orgametril 10 mg/die), danazol (600 mg/die) and an injection of a GnRH-analogon (Decapeptyl-Depot) was compared with a control group without pretreatment. The subjective estimation of the surgeon (endometrial thickness and depth of coagulation) showed a sufficient pretreatment in 90 % of all cases following danazol- and GnRH-analogon-pretreatment. In 90 % of the danazol- and GnRH-analogon pretreated group the histological findings showed also an atrophic or little proliferative endometrium. In a follow up of 6 months after endometrial ablation the highest amenorrhoea-rates were reached following danazol- and GnRH-analogon pretreatment. These two regimes should be used for the pretreatment for endometrial ablation.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Premedicación
/
Pamoato de Triptorelina
/
Danazol
/
Congéneres de la Progesterona
/
Endometrio
/
Antagonistas de Estrógenos
/
Luteolíticos
/
Linestrenol
/
Menorragia
Tipo de estudio:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Límite:
Adult
/
Female
/
Humans
/
Middle aged
Idioma:
De
Revista:
Zentralbl Gynakol
Año:
1996
Tipo del documento:
Article